The final intraoperative parathyroid hormone level: how low should it go?

Area of Science:

• Endocrinology
• Surgical Oncology
• Minimally Invasive Surgery

Background:

• Minimally invasive surgery for primary hyperparathyroidism (HPT) benefits from intraoperative parathyroid hormone (IOPTH) monitoring.
• Optimal criteria for IOPTH monitoring in HPT surgery remain debated.

Purpose of the Study:

• To evaluate the effectiveness of IOPTH monitoring in predicting surgical success and recurrence in primary HPT.
• To establish optimal IOPTH criteria for successful parathyroidectomy.

Main Methods:

• Analysis of 1,108 initial parathyroid operations for sporadic HPT using IOPTH monitoring (1997-2011).
• Outcomes stratified by final post-resection IOPTH levels.
• Adequate follow-up to confirm cure.

Main Results:

• Parathyroidectomy failure occurred in 1.2% of cases, with 0.5% long-term recurrence.
• Surgical success rates were similar for final IOPTH levels of 41-65 pg/mL versus ≤40 pg/mL (p=1).
• Failure was significantly higher if IOPTH did not drop to ≤65 pg/mL (13% vs. 0.3%; p<0.001) or drop by >50% (3.8% vs. 0.2%; p=0.015).
• Long-term recurrence was more likely with final IOPTH 41-65 pg/mL (1.2% vs. 0%; p=0.016).

Conclusions:

• Intraoperative PTH monitoring is crucial for high cure rates in sporadic HPT surgery.
• A final IOPTH within the normal range and a >50% drop from baseline strongly predict operative success.
• Patients with a final IOPTH of 41-65 pg/mL require follow-up beyond 6 months to monitor for recurrence.